Photo: Sam Owens, Charleston Gazette-MailEric Eyre’s investigative series, Painkiller Profiteers, chronicled massive pain pill shipments to West Virginia. This shows the cremated ashes of a West Virginia woman who died from a drug overdose.
Lack of work, educational gaps, despair, overprescribing – there’s a host of reasons behind the nation’s opioid crisis. It may seem daunting to reporters who want to nail down the epidemic’s causes, but sometimes you just have to keep digging – literally.
West Virginia reporter Eric Eyre realized something was off when, during a trip to the state pharmacy board, he began digging through boxes filled with faxes from drug wholesalers reporting suspicious pharmacy activity. Continue reading →
President Donald Trump has spoken about the cost of drugs frequently. Though not always clearly and consistently, he has called for government negotiation of prices. Drug prices also have caught Congress’s eye, although we’re not quite sure what (if anything) legislators are willing to do about it.
Local pharmacies have limited hours? Turns out that this is way more than an inconvenience. It may also be a factor in hospital readmissions. Patients who can’t easily get their medications from an accessible, nearby – and open! – pharmacy are more likely to end up back in the hospital.
Experts have been exploring possible reasons why so many patients bounce in and out of the hospital, and why it’s been hard to bring down the 30-day readmission rates, even with new financial incentives under the Affordable Care Act. Continue reading →
Mylan’s price hike for its EpiPen allergy medication fueled an Internet storm this week, with consumers and U.S. legislators expressing outrage over its decision to raise the price about 400% since 2007 to as much as $500 or more. The backlash appeared tied in part to timing as U.S. children head back to school, with parents of those needing EpiPens to treat allergic reactions coming to grips with the hefty price tag.
The incident brought echoes of another drug price hike – the 2015 increase by Turing Pharmaceutical’s malaria and HIV medicine Darapim, another move that brought scrutiny by the House Oversight and Government Reform Committee of the company’s chief executive officer. Continue reading →
Drug prices have become a hot topic – and a significant source of the ongoing challenges to achieving affordable premiums and out-of-pocket costs in both Affordable Care Act exchange plans and employer-sponsored coverage. Drug costs are now the single largest health care concern of Americans across the political spectrum, according to some polls.
But it can be hard to know where to go to find out information about drug pricing and drug value (which aren’t the same thing). Continue reading →